The Dart Maker Blog

Mass tort status is being considered in the lawsuits that have been filed against the makers of the oral contraceptives Yasmin or Yaz and its generic form Ocella. This is largely due to the increasing number of suits being filed across the country where victims claim stroke and other serious health problems caused by taking Yaz or Ocella. Yaz side effects run the gamut from ischemic stroke or heart attack, to pulmonary embolism and other blood clot related injuries.

Among the recent tilts surrounding Yasmin, Yaz and Ocella birth control, the contraceptives also include drospirenone, an ingredient not in other oral contraceptives. The British Medical Journal issued studies in August 2009 diplaying a higher risk of venous blood clots in adult females taking drospirenone as opposed to those who used other oral contraceptives. In that same month, the Food & Drug Administration issued an uncorrelated warning letter to Bayer Pharmaceuticals, makers of Yaz, for using low-quality batches of drospirenone from a plant in Germany. For the benefit of public interest and wellbeing, these articles have been made available free online.

Adult Females taking Yasmin, Yaz or Ocella to avoid getting pregnant or to treat PMDD (Premenstrual Dysphoric Disorder) or severe acne have reportedly sustained extreme injury to their health and wellbeing. Although most pharmaceuticals present some form of side effects, the main topic surrounding Yaz seems to be that the original commercials downplayed the health risks and side effects. This attracted users to the product that may not have taken it otherwise had they been properly informed about the risks posed by Ocella, Yasmin and Yaz.